logo

Dbv Technologies S.A. - (DBVT)



Trade DBVT now with
  Date
  Headline
2/21/2020 10:10:35 AM DBV Tech Says FDA Advisory Committee Meeting To Review Viaskin Peanut For Treatment Of Peanut Allergy In Children
10/9/2019 1:44:24 AM DBV Technologies Reports Pricing Of $125 Mln Global Offering Of Ordinary Shares
6/26/2019 1:32:46 AM DBV Technologies Appoints Pharis Mohideen As Chief Medical Officer
12/20/2018 6:16:27 AM Jefferies Lowers DBV Technologies S.A. - (DBVT) To Hold From Buy With $8 Down From $37 Price Target
12/12/2018 1:33:28 AM DBV Tech Highlights Data Supporting Induction Of Immunotolerance Through Skin At Inflammatory Skin Disease Summit
10/26/2018 1:35:15 AM DBV Technologies Begins Part B Of Phase III Study In Peanut-Allergic Toddlers
10/22/2018 1:33:10 AM DBV Technologies Announces Submission Of BLA For Viaskin Peanut To FDA
9/12/2018 1:32:22 AM DBV Technologies Report Positive DSMB Review Of Part A Of Phase III Study In Peanut-Allergic Toddlers
5/29/2018 1:33:34 AM DBV Technologies Shows Commitment To The Development Of Treatments For Food Allergies At EAACI 2018
3/21/2018 3:32:28 AM DBV Technologies Reports Pricing Of $150.0 Mln Global Offering Of Ordinary Shares
  
 
>